Highlights and News

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue - Nature

Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue  Nature

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition - Frontiers

Deciphering the molecular landscape of rheumatoid arthritis offers new insights into the stratified treatment for the condition  Frontiers

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials - The Lancet

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials  The Lancet

Clinical implications of synovial tissue phenotypes in rheumatoid arthritis - Frontiers

Clinical implications of synovial tissue phenotypes in rheumatoid arthritis  Frontiers

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial - Nature

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial  Nature

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts - The Lancet

Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts  The Lancet

Oral Presentation Abstracts - 2024 - International Journal of Rheumatic Diseases - Wiley Online Library

Oral Presentation Abstracts - 2024 - International Journal of Rheumatic Diseases  Wiley Online Library

Sankey diagram depicting treatment sequencing for bDMARDs in patients... - ResearchGate

Sankey diagram depicting treatment sequencing for bDMARDs in patients...  ResearchGate

Clinical Applications of Synovial Biopsy - Frontiers

Clinical Applications of Synovial Biopsy  Frontiers

Are innovation and new technologies in precision medicine paving a new era in patients centric care? - Journal of Translational Medicine

Are innovation and new technologies in precision medicine paving a new era in patients centric care?  Journal of Translational Medicine

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis - Nature

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis  Nature

Table 1 Identification of poor prognostic factors in randomized trials... - ResearchGate

Table 1 Identification of poor prognostic factors in randomized trials...  ResearchGate

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis - Frontiers

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis  Frontiers

Rheumatoid arthritis - The Lancet

Rheumatoid arthritis  The Lancet

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics - Nature

Prediction of response of methotrexate in patients with rheumatoid arthritis using serum lipidomics  Nature

Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis - Frontiers

Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis  Frontiers

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy - Frontiers

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy  Frontiers

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes - Frontiers

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes  Frontiers

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs - Frontiers

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs  Frontiers